| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.15 | 0.006 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.007 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.082 | 0.009 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.009 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.13 | 0.009 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.01 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |